Regeneron Pharmaceuticals Inc. buy Cantor Fitzgerald
Summary
This prediction is currently active. With a performance of 2.41%, the BUY prediction by Cantor_Fitzgerald for Regeneron Pharmaceuticals Inc. is trending in the right direction. Dividends of €0.94 are taken into consideration when calculating the performance. This prediction currently runs until 23.04.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 8.058% | 8.058% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by Cantor_Fitzgerald for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
31.07.26
31.07.27
10:18
Regeneron Pharmaceuticals Inc.
06.07.26
06.07.27
10:18
Regeneron Pharmaceuticals Inc.
02.02.26
02.02.27
10:18
Regeneron Pharmaceuticals Inc.
29.10.25
29.10.26
10:18

